|
|
 |
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer. The F.D.A. approved the pill to be taken once daily in combination with Xeloda, from Roche, for treatment of advanced breast cancer in women who carry the HER-2 gene, which accelerates tumor growth, and do not respond to Roche's drug Herceptin, Glaxo said in a statement. Tykerb belongs to a class of drugs called dual-kinase inhibitors, which impede...
March 14, 2007 Business News
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
March 14, 2007 Health News
THIS ESSAY IS BY H. GILBERT WELCH, STEVEN WOLOSHIN and LISA M. SCHWARTZ.
Increased survival sounds like great news. But it may not mean what you think.
March 13, 2007 Health News
By ANDREW POLLACK
The move follows recent studies suggesting that the medications might cause heart attacks.
March 10, 2007 Health News
MORE ON CANCER AND: HEART, EPOGEN (DRUG), PROCRIT (DRUG), DRUGS (PHARMACEUTICALS), ARANESP (DRUG), LABELING AND LABELS, CONSUMER PROTECTION, ANEMIA, JOHNSON & JOHNSON INC, FOOD AND DRUG ADMINISTRATION, AMGEN INC
By MURRAY CHASS
Red Sox pitcher Jon Lester is returning to baseball after being told he had cancer during his rookie season.
March 8, 2007 Sports News
By GINA KOLATA
The scans do not appear to save lives and expose people to serious risks, researchers are reporting.
March 7, 2007 Health News
The Red Sox left-hander Jon Lester pitched in his first game since his last cancer treatment only two and a half months ago. His mechanics and his command were good yesterday, and he retired all three batters he faced on grounders in a B game against the Minnesota Twins in Fort Myers, Fla.
March 6, 2007 News
By MARGARET FARLEY STEELE
ALTHOUGH the debate over the benefits of routine lung-cancer screening remains unresolved, some local hospitals are taking the lead and encouraging smokers and other high-risk patients to obtain low-dose CT scans in the belief that early detection will save lives.
March 4, 2007 Health News
One in four women ages 14 to 59 is infected with HPV, the sexually transmitted virus that in some forms can cause cervical cancer, according to the first broad national estimate. The figure, reported by the Centers for Disease Control and Prevention, is mostly in line with previous assessments. ''We expected the prevalence of any HPV infection would be high, and that's what we found,'' said Dr. Eileen Dunne, the lead author.
February 28, 2007 News
By ANDREW POLLACK
New reports are raising questions about whether drugs that have been used by cancer patients might actually be harming them.
February 27, 2007 Health News
MORE ON CANCER AND: ARANESP (DRUG), EPOGEN (DRUG), PROCRIT (DRUG), DRUGS (PHARMACEUTICALS), CHEMOTHERAPY, SALES, CERA (DRUG), NEORECORMON (DRUG), EPOGIN (DRUG), RESEARCH, EPREX (DRUG), ANEMIA, JOHNSON & JOHNSON INC, FOOD AND DRUG ADMINISTRATION, ROCHE HOLDING LTD, AMGEN INC
By NICHOLAS BAKALAR
The authors of a new study say the explanation for positive studies backed by drug companies might have little to do with bias.
February 27, 2007 Health News
By LISA SANDERS, M.D.
A case in which being too buff can lead to a serious problem.
February 25, 2007 Health News
The American biotechnology company Genentech said Thursday that a low dose of its cancer drug Avastin worked just as well as a more expensive high dose in a clinical trial of patients with lung cancer. Genentech's shares fell 2.5 percent amid concern that the company, as well as its majority owner, Roche Holdings of Switzerland, would receive less revenue from the drug if doctors chose the low-dose version.
February 23, 2007 Business News
By ANDREW POLLACK and STEPHANIE SAUL
Public reaction forced the drug manufacturer to ends its lobbying efforts in state legislatures on behalf of a cervical cancer vaccine.
February 21, 2007 Health News
MORE ON CANCER AND: HUMAN PAPILLOMA VIRUS (HPV), STATES (US), SEX, GARDASIL (DRUG), VACCINATION AND IMMUNIZATION, DRUGS (PHARMACEUTICALS), CHILDREN AND YOUTH, WOMEN, LAW AND LEGISLATION, LOBBYING AND LOBBYISTS, HAUPT, RICHARD M, PERRY, RICK, MERCK & COMPANY INC, MERCK & CO INC
A Pennsylvania jury awarded $3 million on Tuesday to an Ohio woman who claimed a hormone replacement drug made by Wyeth had caused her breast cancer. The woman, Jennie Nelson, 67, of Dayton, was found to have breast cancer in 2001 after taking the drug, Prempro, for five years to treat symptoms of menopause. Her lawyers said Wyeth knew for decades the drug could cause breast cancer but had failed to warn patients.
February 21, 2007 Business News
|
|
 |
|
|
|
|
|
